Related references
Note: Only part of the references are listed.Preventive but Not Late Amiloride Therapy Reduces Morbidity and Mortality of Lung Disease in βENaC-overexpressing Mice
Zhe Zhou et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Development of chronic bronchitis and emphysema in β-epithelial Na+ channel-overexpressing mice
Marcus A. Mall et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Modelling dysregulated Na+ absorption in airway epithelial cells with mucosal nystatin treatment
Alessandra Livraghi et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2008)
Role of cilia, mucus, and airway surface liquid in mucociliary dysfunction: Lessons from mouse models
Marcus A. Mall
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY (2008)
Pharmacological properties of N-(3,5-diamino-6-chloropyrazine-2-carbonyl)-N′-4-[4-(2,3-dihydroxypropoxy)phenyl]butyl-guanidine methanesulfonate (552-02), a novel epithelial sodium channel blocker with potential clinical efficacy for cystic fibrosis lung disease
Andrew J. Hirsh et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Identification of a key pathway required for the sterile inflammatory response triggered by dying cells
Chun-Jen Chen et al.
NATURE MEDICINE (2007)
Proteases and emphysema
A Churg et al.
CURRENT OPINION IN PULMONARY MEDICINE (2005)
Neonatal adaptive immunity comes of age
B Adkins et al.
NATURE REVIEWS IMMUNOLOGY (2004)
Increased airway epithelial Na+ absorption produces cystic fibrosis-like lung disease in mice
M Mall et al.
NATURE MEDICINE (2004)
Death by necrosis - Uncontrollable catastrophe, or is there order behind the chaos?
P Syntichaki et al.
EMBO REPORTS (2002)
Share Paper
